Grifols SA (GRF):企業の財務・戦略的SWOT分析

◆英語タイトル:Grifols SA (GRF) - Financial and Strategic SWOT Analysis Review
◆商品コード:SWOT20MY1678
◆発行会社(調査会社):GlobalData
◆発行日:2020年4月
◆ページ数:72
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:スペイン
◆産業分野:Pharmaceuticals and Healthcare
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD125 ⇒換算¥13,125見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD250 ⇒換算¥26,250見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD375 ⇒換算¥39,375見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Grifols SA (GRF) – Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
The profile contains critical company information including:

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Grifols SA (Grifols) focuses on improving the health and well-being of people around the world. It conducts research, development, manufacturing and marketing of plasma-derived therapies, hospital pharmacy products and diagnostic technology for clinical use. It produces plasma derived protein therapies for patients suffering with rare, chronic and life-threatening infections. Grifols offers biological materials for clinical trials, biotechnology research, manufacturing pharmaceutical and diagnostic products. The company has plasma donation centers across the US. Grifols provides transfusion medicine, hemostasis and immunoassay solutions for blood banks, clinical laboratories and transfusion centers. The company offers products to hospitals, pharmacies and healthcare professionals. Grifols is headquartered in Barcelona, Spain.

Grifols SA Key Recent Developments

Mar 27,2020 Grifols and Shanghai RAAS close their strategic alliance in China
Mar 26,2020 Grifols teams up with US to test plasma therapy for Covid-19
Mar 25,2020 Grifols announces formal collaboration with US Government to produce the first treatment specifically targeting COVID-19
Feb 27,2020 Grifols reaches revenue of EUR 5,100 million, a 13.6% increase, and raises its profits to EUR 625 million

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

【レポートの目次】

Table of Contents
Table of Contents
List of Tables
List of Figures
Section 1 – About the Company
Grifols SA – Key Facts
Grifols SA – Key Employees
Grifols SA – Key Employee Biographies
Grifols SA – Major Products and Services
Grifols SA – History
Grifols SA – Company Statement
Grifols SA – Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Section 2 – Company Analysis
Company Overview
Grifols SA – Business Description
Business Segment: Bio Supplies
Overview
Performance
Business Segment: Bioscience
Overview
Performance
Key Stats
Business Segment: Diagnostic
Overview
Performance
Key Stats
Business Segment: Hospital
Overview
Performance
Business Segment: Others
Overview
Performance
Geographical Segment: European Union
Performance
Geographical Segment: Rest of World
Performance
Geographical Segment: Spain
Performance
Geographical Segment: USA and Canada
Performance
R&D Overview
Grifols SA – SWOT Analysis
SWOT Analysis – Overview
Grifols SA – Strengths
Grifols SA – Weaknesses
Grifols SA – Opportunities
Grifols SA – Threats
Grifols SA – Key Competitors
Section 3 – Company Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Performance Chart
Financial Performance
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts
Section 4 – Company’s Lifesciences, Power Financial Deals and Alliances
Grifols SA, Pharmaceuticals & Healthcare, Deals By Year, 2014 to YTD 2020
Grifols SA, Pharmaceuticals & Healthcare, Deals By Type, 2014 to YTD 2020
Grifols SA, Recent Deals Summary
Section 5 – Company’s Recent Developments
Mar 27, 2020: Grifols and Shanghai RAAS close their strategic alliance in China
Mar 26, 2020: Grifols teams up with US to test plasma therapy for Covid-19
Mar 25, 2020: Grifols announces formal collaboration with US Government to produce the first treatment specifically targeting COVID-19
Feb 27, 2020: Grifols reaches revenue of EUR 5,100 million, a 13.6% increase, and raises its profits to EUR 625 million
Feb 13, 2020: Grifols PharmacyKeeper ranked No. 1 in KLAS rating, extends category leadership
Dec 05, 2019: Grifols streamlines Hospital Pharmacy operations with new KIRO Fill technology and PharmacyKeeper enhancements
Jul 31, 2019: Grifols increases its revenues by 14.3% to EUR 2,423 million, driven by its strategic growth plan
Jul 03, 2019: Grifols selected to build its first intravenous solutions manufacturing line in Africa
May 24, 2019: Grifols reinforces its long-term and sustainable growth strategy with EUR 1,400 million in capital investments in 2018-2022
May 08, 2019: Grifols reports 13% revenue growth to EUR 1,157 million and confirms its solid operational performance
Section 6 – Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

List of Tables
Grifols SA, Key Facts
Grifols SA, Key Employees
Grifols SA, Key Employee Biographies
Grifols SA, Major Products and Services
Grifols SA, History
Grifols SA, Other Locations
Grifols SA, Subsidiaries
Grifols SA, Key Competitors
Grifols SA, Ratios based on current share price
Grifols SA, Annual Ratios
Grifols SA, Annual Ratios (Cont...1)
Grifols SA, Annual Ratios (Cont...2)
Grifols SA, Interim Ratios
Grifols SA, Pharmaceuticals & Healthcare, Deals By Year, 2014 to YTD 2020
Grifols SA, Pharmaceuticals & Healthcare, Deals By Type, 2014 to YTD 2020
Grifols SA, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

List of Figures
Grifols SA, Performance Chart (2015 - 2019)
Grifols SA, Ratio Charts
Grifols SA, Pharmaceuticals & Healthcare, Deals By Year, 2014 to YTD 2020
Grifols SA, Pharmaceuticals & Healthcare, Deals by Type, 2014 to YTD 2020

★海外企業調査レポート[Grifols SA (GRF):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Aksigorta A.S. (AKGRT):企業の財務・戦略的SWOT分析
    Aksigorta A.S. (AKGRT) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses an …
  • Sinohydro Corporation Co Ltd-エネルギー分野:企業M&A・提携分析
    Summary Sinohydro Corporation Co., Ltd (Sinohydro) a subsidiary ofPower Construction Corporation of Chinais a global engineering and construction company. It is a state-owned hydropower project contractor with focus on the development of residential, commercial, and industrial properties across the …
  • Genesis Energy, L.P.:企業の戦略・SWOT・財務分析
    Genesis Energy, L.P. - Strategy, SWOT and Corporate Finance Report Summary Genesis Energy, L.P. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • SPAR International:企業の戦略・SWOT・財務分析
    SPAR International - Strategy, SWOT and Corporate Finance Report Summary SPAR International - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • TOTAL S.A.:企業の戦略・SWOT・財務情報
    TOTAL S.A. - Strategy, SWOT and Corporate Finance Report Summary TOTAL S.A. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actio …
  • NRG Energy Inc (NRG):企業の財務・戦略的SWOT分析
    NRG Energy Inc (NRG) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Origin Energy Ltd (ORG)-石油・ガス分野:企業M&A・提携分析
    Summary Origin Energy Limited (Origin Energy) is an integrated energy company. It generates, supplies and distributes electricity; explores and develops natural gas reserves; and produces and sells gas. The company generates electricity from natural-gas fired, coal-fired, wind, solar, pumped water s …
  • Essential Energy:企業の戦略的SWOT分析
    Essential Energy - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and servi …
  • IRX Therapeutics Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary IRX Therapeutics Inc (IRX Therapeutics) is a clinical-stage bioresearch company that develops immunotherapies which reduces the immune suppression. The company provides product that overcomes cancer induced immune suppression and restores anti-tumor response. It offers product IRX-2 which is …
  • Electricity Generation Company of Bangladesh Ltd:企業の戦略的SWOT分析
    Electricity Generation Company of Bangladesh Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competit …
  • BioStem Technologies Inc (BSEM):製薬・医療:M&Aディール及び事業提携情報
    Summary BioStem Technologies Inc. (BioStem Technologies), formerly Caribbean International Holdings Inc., is a life sciences company that discovers, develops and manufactures pharmaceuticals and regenerative medicines. Through its subsidiaries, the company discovers, develops, produces and commercia …
  • Universal Display Corp (OLED):企業の財務・戦略的SWOT分析
    Summary Universal Display Corp (UDC) is a clean technology company that conducts research, develops and markets organic light emitting diode, technologies and materials. The company offers PHOLED materials which are used in making OLED displays and lighting panels. It provides technologies such as F …
  • ZF Friedrichshafen AG:企業の戦略的SWOT分析
    ZF Friedrichshafen AG - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and …
  • Isrotel Hotels Management Inc.
    Isrotel Hotels Management Inc. - Strategy, SWOT and Corporate Finance Report Summary Isrotel Hotels Management Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product a …
  • Exploration and Production KazMunaiGas (KMG):石油・ガス:M&Aディール及び事業提携情報
    Summary Exploration and Production KazMunaiGas (KMG EP), a subsidiary of National Company KazMunaiGas, is an upstream oil and gas company. The company carries out the exploration, development, production, processing and export of hydrocarbons and acquisition of oil and gas assets in Kazakhstan. Its …
  • Sino Gas & Energy Holdings Ltd (SEH):石油・ガス:M&Aディール及び事業提携情報
    Summary Sino Gas & Energy Holdings Ltd (Sino Gas), a subsidiary of MIE Holdings Corp, is an oil and gas company that explores and develops unconventional gas assets production sharing contracts. The company holds working interest in the Linxing PSC and the Sanjiaobei PSC projects. It has strategic A …
  • El Paso Electric Company (EE):企業の財務・戦略的SWOT分析
    El Paso Electric Company (EE) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakne …
  • TNT Crane and Rigging Inc:石油・ガス:M&Aディール及び事業提携情報
    Summary TNT Crane and Rigging Inc (TNT) is a construction company that offers crane rental services. The company provides equipment such as mobile hydraulic truck cranes, gantry jacks and sliders, forklifts and specialty lifts, tractors and trailers, among others. It offers rigging equipment, all-te …
  • The Toronto-Dominion Bank:企業の戦略・SWOT・財務情報
    The Toronto-Dominion Bank - Strategy, SWOT and Corporate Finance Report Summary The Toronto-Dominion Bank - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …
  • Genting Singapore Plc:戦略・SWOT・企業財務分析
    Genting Singapore Plc - Strategy, SWOT and Corporate Finance Report Summary Genting Singapore Plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆